https://www.viatrisconnect-eg.com/ar-EG 2026-02-26 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/About-Viatris 2026-03-08 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Consent 2023-12-14 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Contact-Us 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Events 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Login 2025-10-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Profile 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Registration 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Therapeutic-Areas 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio 2025-11-28 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Pharma-Zone 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Adverse-Events-Reoprting 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-Information 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/HCPUserLogin 2021-11-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Privacy-Policy 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Terms-and-Conditions 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/404 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/500 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/About-Viatris/Our-Story 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/About-Viatris/A-New-Kind-of-Healthcare-Company 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/About-Viatris/Our-Mission-and-Vision 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/About-Viatris/Our-Pipeline 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/About-Viatris/Our-Commitment-to-Quality 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Events/Webinars 2021-11-05 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/HealthConnect 2021-11-05 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Therapeutic-Areas/Cardiovascular 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Therapeutic-Areas/Mental-Health 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Therapeutic-Areas/Pain 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Therapeutic-Areas/Urology-Mens-Health 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Cardura 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Cardura-XL 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Celebrex 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Detrusitol 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Efexor-xr 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lipitor 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lustral 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lyrica 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Neurontin 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Norvasc 2026-04-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Norvasc-VAL 2026-04-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/VIAGRA 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xalacom 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xalatan 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xanax 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/HealthConnect/Cardio 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/OVID 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/A-Comparison-of-Two-LDL-Cholesterol-Targets-after-Ischemic-Stroke 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Abdominal-Obesity-is-Associated-with-Early-All-Cause-Mortality 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Accuracy-of-Patient-Reported-Passage-of-Ureteral-Stones 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Adverse-Pregnancy-Outcomes-are-Associated-with-Future-Cardiovascular-Risk 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/An-Easy-Screen-for-Left-Ventricular-Dysfunction 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Anxiety-and-Depression-can-Make-You-Sick 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Aortic-Stenosis-and-Dyslipidemia 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Associated-Mental-Disorders-and-Physical-Conditions 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Associations-Between-Blood-Pressure-and-Cognitive-Decline 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Atrial-Fibrillation-Updates 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Breast-Cancer-Risk-Treatment-Management-and-Genetic-Testing 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Cardiovascular-Risks-During-the-Menopause-Transition 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Cervical-Cancer-and-the-Benefits-of-HPV-Vaccinations 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Coronary-Disease-Risk-Score-Predicts-Progression-of-Atherosclerosis-on-Computed-Tomography 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Detecting-Metastatic-Prostate-Cancer-with-Prostate-Specific-Membrane-Antigen-PET-CT 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Diagnosing-and-Predicting-Development-of-Rheumatoid-Arthritis 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Effects-of-HPV-Vaccination-on-Risk-for-Cervical-Cancer 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Endovascular-Thrombectomy-for-Acute-Ischemic-Stroke 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Guidance-in-Evaluation-of-Microscopic-Hematuria 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Hip-Fracture-Care-A-step-in-the-right-direction 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Intensity-of-Physical-Activity-and-Risk-for-Death 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Is-Stroke-Risk-in-Patients-with-Transient-Ischemic-Attack-Decreasing 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Issues-in-Arthroplasty-Care 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Long-Term-Blood-Pressure-Variability-Is-Associated-with-Structural-and-Functional 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/MRI-Scores-for-Cerebral-Small-Vessel-Disease-and-Prediction-of-Dementia 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/MRI-with-Biopsy-for-Prostate-Cancer-Diagnosis 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Mycoplasma-genitalium-Urethritis-Prevalence-and-Drug-Resistance-Patterns 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Neither-Vigorous-Activity-Nor-Sedentary-Behavior-is-Asociated-with-Risk-for-Knee-Osteoarthritis 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Nonclassic-TIA-Symptoms-and-Stroke-Risk 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Outcomes-are-Worse-in-STEMI-Patients-Without-Traditional-Cardiovascular-Risk-Factors 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Pain-Tolerability-and-the-10-Point-Scale 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Preventing-Serious-Fall-Injuries 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Psychiatric-Disorders-across-the-Lifespan--A-Unitary-Psychopathology-Factor-Best-Fits-the-Data 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Renal-Ultrasound-for-Evaluating-Asymptomatic-Microscopic-Hematuria 2022-01-19 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/The-World-Brain-Death-Project 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/Medical-Journal/Two-Schizophrenias 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Therapeutic-Areas/Cardiovascular/Cardiovascular-Disease-Mortality 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Therapeutic-Areas/Cardiovascular/Blood-Pressure-Variability 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Therapeutic-Areas/Cardiovascular/Cardiovascular-Risk-Factors 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Therapeutic-Areas/Cardiovascular/Hypertension-Burden 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Therapeutic-Areas/Cardiovascular/Type-2-Diabetes-as-a-CHD-Equivalent 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Therapeutic-Areas/Mental-Health/Mental-Health-Conditions-Burden 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Therapeutic-Areas/Mental-Health/Major-Depressive-Disorders-Prevalence 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Therapeutic-Areas/Mental-Health/Anxiety-Prevalence 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Therapeutic-Areas/Mental-Health/Depression-and-Coronary-Heart-Disease 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Therapeutic-Areas/Mental-Health/Depression-and-Diabetes-Mellitus 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Therapeutic-Areas/Pain/Chronic-Low-Back-Pain-Neuropathic-Component 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Therapeutic-Areas/Pain/DPN-Prevalence-in-Diabetic-Patients 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Therapeutic-Areas/Pain/Neuropathic-Pain-Means-More-than-Pain-for-your-Patients 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Therapeutic-Areas/Pain/Prevalence-of-Chronic-Low-Back-Pain 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Therapeutic-Areas/Pain/Screening-Neuropathic-Pain 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Therapeutic-Areas/Urology-Mens-Health/Erection-Hardness-Score-Evaluation 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Therapeutic-Areas/Urology-Mens-Health/Lower-Urinary-Tract-Prevalence-and-Symptoms 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Therapeutic-Areas/Urology-Mens-Health/Neuropathic-Pain-Means-More-than-Pain-for-your-Patients 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Therapeutic-Areas/Urology-Mens-Health/Prevalence-of-ED-Comorbidites 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Therapeutic-Areas/Urology-Mens-Health/Symptoms-of-Erectile-Dysfunction 2026-03-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Cardura/Summary-of-Product-Characteristics---Cardura-XL 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Cardura/CARDURATM-XL-produced-significantly-greater-improvements 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Cardura/Fast-Relief-with-CarduraTM-XL 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Cardura/CARDURA-XL-Favorable-Ejaculatory-Safety 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Cardura/CarduraTM-XL-Outperforms-Tamsulosin 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Cardura/CARDURATM-XL-Safety-Profile 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Cardura/Improved-IPSS-with-CARDURA 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Cardura/Summary-of-Product-Characteristics---Cardura 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Cardura-XL/Fast-Relief-with-CarduraTM-XL 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Cardura-XL/CARDURA-XL-Favorable-Ejaculatory-Safety 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Cardura-XL/CarduraTM-XL-Outperforms-Tamsulosin 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Cardura-XL/CARDURATM-XL-Safety-Profile 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Cardura-XL/Improved-IPSS-with-CARDURA 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Celebrex/Celebrex-rapid-onset 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Celebrex/As-effective-as-diclofenac-in-the-treatment-of-acute-low-back-pain 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Celebrex/Celebrex-is-effective-in-reducing-pain-after-laparoscopic-surgery 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Celebrex/CELEBREX-provides-a-rapid-and-sustained-control-of-OA-pain-and-inflammation 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Celebrex/Celebrex-significantly-improves-pain-physical-functioning-and-joint-stiffness 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Celebrex/Effective-Pain-Relief-in-Acute-Low-Back-Pain 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Celebrex/Effective-Pain-Relief-in-Acute-Pain-Shoulder-Tendinitis-Bursitis 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Celebrex/Efficacy 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Celebrex/Safety-Profile 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Celebrex/Summary-of-Product-Characteristics 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Celebrex/Effective-Pain-Relief-in-Postoperative-Acute-Pain 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Detrusitol/OAB-and-Its-Impact-on-Daily-Living 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Detrusitol/Detrusitol-SR-Fast-onset-of-action 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Detrusitol/Detrusitol-SR-Long-Term-Efficacy 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Detrusitol/Efficacy-of-Detrusitol-SR 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Detrusitol/European-Association-of-Urology-Guideline-2020 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Detrusitol/Managing-Nocturia-with-Detrusitol-SR 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Detrusitol/Summary-of-Product-Characteristics 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Detrusitol/Tolerability-of-Detrusitol-SR 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Efexor-xr/EFEXOR-XR-for-your-adult-patients-with-major-depressive-disorder 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Efexor-xr/Efexor-XR-is-an-effective-and-well-tolerated-treatment-for-patients-with-Major-Depressive-Disorder 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Efexor-xr/Efexor-XR-maintenance-therapy-is-effective-in-preventing-recurrence-of-depression-in-patients 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Efexor-xr/Efexor-XR-offers-efficacy-and-tolerability-in-patient-with-generalized-anxiety-disorder 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Efexor-xr/Efexor-XR-provides-a-once-daily-dosing-regimen 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Efexor-xr/Efexor-XR-was-shown-to-be-an-effective-treatment-of-very-elderly-primary-care 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Efexor-xr/Perahia-study-results 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Efexor-xr/Summary-of-Product-Characteristics 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lipitor/ESC-2025-Focused-Update-of-the-2019-ESC 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lipitor/Guidelines-for-the-Management-of-Patients-With-Acute-Coronary-Syndromes 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lipitor/Guidelines-recommendations 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lipitor/Indications 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lipitor/LIPITOR-80-mg-reduced-proteinuria-and-maintained-eGFR-in-patients-with-CKD 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lipitor/LIPITOR-reduces-CV-events-in-patients-with-multiple-CV-risk-factors 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lipitor/SAFETY 2026-04-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lipitor/Dosing-and-Administration 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lipitor/Efficacy--Intensive-Lipid-Lowering-Effect 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lipitor/Efficacy--Reduced-risk-of-major-cardiovascular-disease 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lipitor/Efficacy--Reduced-the-risk-of-stroke 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lipitor/Summary-of-Product-Characteristics 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lipitor/Treatment-Duration 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lustral/Choose-Lustral 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lustral/Pharmacologic-Properties 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lustral/Greater-efficacy-than-placebo-in-preventing-dropout 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lustral/Lustral-is-significantly-more-effective-than-placebo-in-treatment-of-major-depression 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lustral/Proven-Efficacy-and-Safety-of-Lustral-in-the-short-treatment-of-patients 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lustral/SADHART 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lustral/Summary-of-Product-Characteristics 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lustral/Flexible-once-daily-dosing-across-several-indications 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lustral/Significant-reductions-in-symptom-severity-in-many-clinically-relevant-dimensions-of-panic-disorder 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lustral/Significantly-better-effectiveness-and-tolerability-of-Lustral-treatment-in-clinical-practice 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lyrica/Analgesic-effect-when-used-long-period 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lyrica/Neuropathic-Pain 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lyrica/Flexible-dose-of-LYRICA-shows-Significant-Improvements-in-Pain-Sleep-and-Anxiety-Scores 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lyrica/LYRICA-Pregabalin 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lyrica/LYRICA-shows-significant-reductions-in-end-point-least-squares 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lyrica/Summary-of-Product-Characteristics 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lyrica/Guidelines-Recommendations 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lyrica/Pharmacokinetics-Drug-interactions 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Lyrica/Safety 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Neurontin/Decoding-Diabetic-peripheral-neuropathy 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Neurontin/Guideline-Based-Recommendations-for-Gabapentin 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Neurontin/Neurontin-Proven-Efficacy 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Neurontin/Neuropathic-Pain-More-Than-Just-Pain 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Neurontin/Summary-of-Product-Characteristics 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Neurontin/Neurontin-Dose-Overview 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Neurontin/Sleep-and-QoL-in-DPN-Neurontins-Impact 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Norvasc/Summary-of-Product-Characteristics-Norvasc-Val 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Norvasc/INDICATIONS-AND-USAGE 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Norvasc/2024-ESC-Guidelines-for-the-management-of-arterial-hypertension 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Norvasc/A-REAL-BURDEN-HYPERTENSION 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Norvasc/Blood-pressure-classification-according-to-ESC-2024-guidelines 2026-04-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Norvasc/CLINICAL-GUIDELINES-FOR-THE-MANAGEMENT-OF-HYPERTENSION 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Norvasc/DOSAGE-AND-ADMINISTRATION 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Norvasc/NORVASC-Lowers-BP-Risk 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Norvasc/Norvasc-Val-Hypertension-Relief 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Norvasc/Norvasc-Val-Safe-Effective 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Norvasc/Norvasc-Val-Stage-2-Hypertension-Efficacy 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Norvasc/PHARMACODYNAMICS-AND-PHARMACOKINETICS 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Norvasc/Summary-of-Product-Characteristics 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Norvasc/VALUE-Trial-NORVASC-Advantage 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Norvasc-VAL/Summary-of-Product-Characteristics-Norvasc-Val 2026-04-10 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Norvasc-VAL/INDICATIONS-AND-USAGE 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Norvasc-VAL/A-REAL-BURDEN-HYPERTENSION 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Norvasc-VAL/CLINICAL-GUIDELINES-FOR-THE-MANAGEMENT-OF-HYPERTENSION 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Norvasc-VAL/DOSAGE-AND-ADMINISTRATION 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Norvasc-VAL/NORVASC-Lowers-BP-Risk 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Norvasc-VAL/Norvasc-Val-Hypertension-Relief 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Norvasc-VAL/Norvasc-Val-Safe-Effective 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Norvasc-VAL/Norvasc-Val-Stage-2-Hypertension-Efficacy 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Norvasc-VAL/PHARMACODYNAMICS-AND-PHARMACOKINETICS 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Norvasc-VAL/VALUE-Trial-NORVASC-Advantage 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/VIAGRA/Erection-hardness-in-patients 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/VIAGRA/Take-Action-for-Sexual-Satisfaction-for-your-ED-Patients 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/VIAGRA/According-to-the-Global-Better-Sex-Survey-erection-hardness-matters 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/VIAGRA/Erectile-Dysfunction-can-impact-men-and-their-sexual-relationships 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/VIAGRA/Erectile-dysfunction-is-associated-with-several-comorbidities 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/VIAGRA/Study-Descriptions 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/VIAGRA/Summary-of-Product-Characteristics 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/VIAGRA/Men-and-women-reported-that-its-important 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/VIAGRA/Satisfaction-with-erection-hardness-correlates 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/VIAGRA/Significantly-greater-percentages-of-ED 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/VIAGRA/The-most-common-adverse-reactions-with-VIAGRA 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/VIAGRA/VIAGRA-TIPS 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/VIAGRA/VIAGRA-treatment-resulted-in-a-grade 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/VIAGRA/With-VIAGRAsignificantly-higher-percentage-of-men-with-ED 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xalacom/Summary-of-Product-Characteristics---Xalacom 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xalacom/Take-Action-for-Sexual-Satisfaction-for-your-ED-Patients 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xalacom/According-to-the-Global-Better-Sex-Survey-erection-hardness-matters 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xalacom/Erectile-Dysfunction-can-impact-men-and-their-sexual-relationships 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xalacom/Erectile-dysfunction-is-associated-with-several-comorbidities 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xalacom/Study-Descriptions 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xalacom/Summary-of-Product-Characteristics 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xalacom/Men-and-women-reported-that-its-important 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xalacom/Satisfaction-with-erection-hardness-correlates 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xalacom/Significantly-greater-percentages-of-ED 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xalacom/The-most-common-adverse-reactions-with-VIAGRA 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xalacom/VIAGRA-TIPS 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xalacom/VIAGRA-treatment-resulted-in-a-grade 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xalacom/With-VIAGRAsignificantly-higher-percentage-of-men-with-ED 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xalatan/Summary-of-Product-Characteristics---Xalatan 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xalatan/Take-Action-for-Sexual-Satisfaction-for-your-ED-Patients 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xalatan/According-to-the-Global-Better-Sex-Survey-erection-hardness-matters 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xalatan/Erectile-Dysfunction-can-impact-men-and-their-sexual-relationships 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xalatan/Erectile-dysfunction-is-associated-with-several-comorbidities 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xalatan/Study-Descriptions 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xalatan/Summary-of-Product-Characteristics 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xalatan/Men-and-women-reported-that-its-important 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xalatan/Satisfaction-with-erection-hardness-correlates 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xalatan/Significantly-greater-percentages-of-ED 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xalatan/The-most-common-adverse-reactions-with-VIAGRA 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xalatan/VIAGRA-TIPS 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xalatan/VIAGRA-treatment-resulted-in-a-grade 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xalatan/With-VIAGRAsignificantly-higher-percentage-of-men-with-ED 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xanax/Summary-of-Product-Characteristics---Xanax 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xanax/Take-Action-for-Sexual-Satisfaction-for-your-ED-Patients 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xanax/According-to-the-Global-Better-Sex-Survey-erection-hardness-matters 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xanax/Erectile-Dysfunction-can-impact-men-and-their-sexual-relationships 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xanax/Erectile-dysfunction-is-associated-with-several-comorbidities 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xanax/Study-Descriptions 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xanax/Summary-of-Product-Characteristics 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xanax/Men-and-women-reported-that-its-important 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xanax/Satisfaction-with-erection-hardness-correlates 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xanax/Significantly-greater-percentages-of-ED 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xanax/The-most-common-adverse-reactions-with-VIAGRA 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xanax/VIAGRA-TIPS 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xanax/VIAGRA-treatment-resulted-in-a-grade 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Viatris-Portfolio/Xanax/With-VIAGRAsignificantly-higher-percentage-of-men-with-ED 2026-03-16 daily 0.5 https://www.viatrisconnect-eg.com/ar-EG/Medical-News/HealthConnect/Cardio/Second-Interistal 2026-03-10 daily 0.5